NDAQ Financial Statements & Analysis
Complete financial statements for NDAQ including income statement, balance sheet, and cash flow statement. Analyze NDAQ's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
49
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
22.0% ↑
Net Income
5.5% ↑
Gross Margin
-3.8% ↓
Operating Margin
-6.6% ↓
Balance Sheet
Current Ratio
-2.2% ↓
Debt to Equity
-12.3% ↑
Asset Turnover
29.7% ↑
Cash Flow
Operating Cash Flow
14.3% ↑
Net Cash Flow
-1803.2% ↓
Free Cash Flow
12.6% ↑
Cash Flow to Debt
25.9% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 6.06B | 7.40B | 22.0% | |
| Gross Profit | 2.55B | 2.99B | 17.4% | |
| Operating Income | 1.58B | 1.80B | 13.9% | |
| Net Income | 1.06B | 1.12B | 5.5% | |
| EPS | 2.08 | 1.94 | 6.7% | |
| EBITDA | 2.00B | 2.46B | 23.2% | |
| Gross Margin | 41.99% | 40.39% | 3.8% | |
| Operating Margin | 26.02% | 24.30% | 6.6% | |
| Net Income Margin | 17.46% | 15.09% | 13.6% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 7.40B | 6.06B | 6.23B | 5.89B | 5.63B |
| Gross Profit | 2.99B | 2.55B | 2.34B | 2.23B | 1.94B |
| Operating Income | 1.80B | 1.58B | 1.56B | 1.44B | 1.23B |
| Net Income | 1.12B | 1.06B | 1.13B | 1.19B | 933.00M |
| EPS | 1.94 | 2.08 | 2.28 | 2.38 | 1.89 |
| EBITDA | 2.46B | 2.00B | 1.85B | 1.93B | 1.51B |
| Gross Margin | 40.39% | 41.99% | 37.57% | 37.92% | 34.52% |
| Operating Margin | 24.30% | 26.02% | 25.12% | 24.48% | 21.94% |
| Net Income Margin | 15.09% | 17.46% | 18.07% | 20.17% | 16.59% |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 |